News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
787,440 Results
Type
Article (70946)
Company Profile (174)
Press Release (716306)
Multimedia
Podcasts (169)
Webinars (26)
Section
Business (212374)
Career Advice (3379)
Deals (37661)
Drug Delivery (142)
Drug Development (87444)
Employer Resources (185)
FDA (17796)
Job Trends (16257)
News (367334)
Policy (37302)
Tag
Academia (2929)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (53241)
ALS (170)
Alzheimer's disease (1746)
Antibody-drug conjugate (ADC) (297)
Approvals (17891)
Artificial intelligence (537)
Autoimmune disease (129)
Automation (33)
Bankruptcy (374)
Best Places to Work (12244)
BIOSECURE Act (23)
Biosimilars (186)
Biotechnology (108)
Bladder cancer (149)
Brain cancer (60)
Breast cancer (602)
Cancer (4606)
Cardiovascular disease (404)
Career advice (2885)
Career pathing (40)
CAR-T (285)
CDC (59)
Celiac Disease (1)
Cell therapy (764)
Cervical cancer (36)
Clinical research (73457)
Collaboration (1571)
Company closure (5)
Compensation (1047)
Complete response letters (64)
COVID-19 (2953)
CRISPR (93)
C-suite (732)
Cystic fibrosis (146)
Data (5747)
Decentralized trials (2)
Denatured (58)
Depression (130)
Diabetes (488)
Diagnostics (7002)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (250)
Drug pricing (205)
Drug shortages (35)
Duchenne muscular dystrophy (222)
Earnings (86495)
Editorial (60)
Employer branding (22)
Employer resources (162)
Events (123006)
Executive appointments (1006)
FDA (20603)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1403)
Gene editing (201)
Generative AI (54)
Gene therapy (614)
GLP-1 (1069)
Government (5305)
Grass and pollen (8)
Guidances (378)
Healthcare (20401)
HIV (53)
Huntington's disease (44)
IgA nephropathy (79)
Immunology and inflammation (271)
Immuno-oncology (39)
Indications (76)
Infectious disease (3222)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (217)
Interviews (645)
IPO (17376)
IRA (59)
Job creations (4379)
Job search strategy (2369)
Kidney cancer (17)
Labor market (82)
Layoffs (648)
Leadership (38)
Legal (9223)
Liver cancer (94)
Longevity (13)
Lung cancer (645)
Lymphoma (358)
Machine learning (38)
Management (63)
Manufacturing (724)
MASH (164)
Medical device (14515)
Medtech (14553)
Mergers & acquisitions (21276)
Metabolic disorders (1273)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (318)
Neuropsychiatric disorders (85)
Neuroscience (2929)
NextGen: Class of 2025 (7213)
Non-profit (4997)
Now hiring (31)
Obesity (613)
Opinion (322)
Ovarian cancer (151)
Pain (185)
Pancreatic cancer (194)
Parkinson's disease (271)
Partnered (32)
Patents (464)
Patient recruitment (398)
Peanut (58)
People (64254)
Pharmaceutical (45)
Pharmacy benefit managers (30)
Phase I (22666)
Phase II (32017)
Phase III (24201)
Pipeline (3792)
Policy (315)
Postmarket research (3223)
Preclinical (9995)
Press Release (71)
Prostate cancer (225)
Psychedelics (52)
Radiopharmaceuticals (281)
Rare diseases (792)
Real estate (6786)
Recruiting (76)
Regulatory (26895)
Reports (52)
Research institute (2643)
Resumes & cover letters (521)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (146)
Series A (233)
Series B (172)
Service/supplier (15)
Sickle cell disease (98)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (46)
Startups (3821)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (109)
Vaccines (1087)
Venture capital (76)
Weight loss (428)
Women's health (73)
Worklife (21)
Date
Today (113)
Last 7 days (680)
Last 30 days (2768)
Last 365 days (32285)
2025 (31324)
2024 (36773)
2023 (41668)
2022 (52930)
2021 (57694)
2020 (56553)
2019 (50046)
2018 (38061)
2017 (35469)
2016 (35799)
2015 (41373)
2014 (35528)
2013 (31394)
2012 (33196)
2011 (33228)
2010 (32288)
Location
Africa (1085)
Alabama (85)
Alaska (7)
Arizona (285)
Arkansas (14)
Asia (46203)
Australia (7986)
California (10483)
Canada (3098)
China (1027)
Colorado (442)
Connecticut (470)
Delaware (312)
Europe (107074)
Florida (1566)
Georgia (347)
Hawaii (3)
Idaho (64)
Illinois (841)
India (60)
Indiana (499)
Iowa (21)
Japan (371)
Kansas (126)
Kentucky (39)
Louisiana (26)
Maine (81)
Maryland (1363)
Massachusetts (7671)
Michigan (328)
Minnesota (608)
Mississippi (6)
Missouri (131)
Montana (33)
Nebraska (25)
Nevada (116)
New Hampshire (81)
New Jersey (2898)
New Mexico (32)
New York (2834)
North Carolina (1461)
North Dakota (9)
Northern California (5012)
Ohio (319)
Oklahoma (22)
Oregon (41)
Pennsylvania (2122)
Puerto Rico (18)
Rhode Island (45)
South America (1478)
South Carolina (60)
South Dakota (1)
Southern California (4086)
Tennessee (164)
Texas (1629)
United States (38045)
Utah (319)
Vermont (1)
Virginia (252)
Washington D.C. (81)
Washington State (858)
West Virginia (4)
Wisconsin (102)
Wyoming (2)
787,440 Results for "crohn s and colitis foundation of america ccfa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Geneoscopy to Present Research on Inflammatory Bowel Disease at Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference
Geneoscopy, Inc. will present research at the Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference in Cambridge, Mass., April 9-10.
April 3, 2024
·
2 min read
Business
Azenta Announces Collaboration with the Crohn’s & Colitis Foundation to Support its Crohn’s Disease and Ulcerative Colitis Clinical Research
Azenta, Inc. (Nasdaq: AZTA) today announced it has been selected by the Crohn’s & Colitis Foundation (the “Foundation”) as its sample management services provider for two of its large-scale prospective research cohorts, CAPTURE IBD and IBD SIRQC, which investigate pediatric and surgical care for Crohn’s disease and ulcerative colitis.
June 4, 2024
·
4 min read
Press Releases
Hope Biosciences Research Foundation Opens Enrollment for FDA-Authorized Crohn’s Disease Stem Cell Trial
August 20, 2025
·
2 min read
Press Releases
Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn’s Disease
November 17, 2025
·
6 min read
Press Releases
Trethera Announces Inflammatory Bowel Disease Poster Presentation at the Annual Crohn’s & Colitis Foundation Congress
January 16, 2025
·
6 min read
Inflammatory bowel disease
Lilly and J&J Face Off in Crohn’s Disease With Phase III Readouts at ACG 2024
Eli Lilly and Johnson & Johnson are seeking label expansions for Omvoh and Tremfya, respectively, in Crohn’s disease following approvals for ulcerative colitis. GlobalData projects total sales for Tremfya to reach $7.8 billion globally by 2029.
October 29, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Trethera Receives $1.8 Million NIH Grant to Advance TRE-515 Development for Crohn’s Disease
September 24, 2025
·
5 min read
Biotech Beach
Palisade Bio Announces Receipt of Second Milestone Payment from the US Crohn’s and Colitis Foundation for Development of PALI-2108
Palisade Bio, Inc. announced the receipt of the second milestone payment to Giiant from the US Crohn’s and Colitis Foundation, through its Inflammatory Bowel Disease Ventures program.
December 28, 2023
·
4 min read
Press Releases
Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn’s and Colitis Congress
February 4, 2025
·
1 min read
Press Releases
Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of Fibrostenotic Crohn’s Disease (FSCD)
October 21, 2025
·
5 min read
1 of 78,744
Next
